Lexicon Pharmaceuticals, Inc. (LXRX) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Lexicon Pharmaceuticals was founded 30 years ago with the ambitious goal of creating knockout mouse lines for 5,000 genes to study their impacts [3] - The company has conducted over 80 clinical trials, leading to the approval of 2 medicines in the United States [4] Product Development - Lexicon has successfully commercialized INPEFA and developed a non-opioid treatment for neuropathic pain, as well as a new non-incretin mechanism for obesity [4]